Alumni Capital LP

Alumni Capital LP is an alternative investment fund specializing in opportunistic and event-driven investments in small-cap companies worldwide. The firm focuses on deploying capital across special situations, event-driven catalysts, and overlooked segments of public equities. While sector-agnostic, it concentrates research and capital in healthcare, natural resources, energy, technology, and consumer markets. The firm has invested across the United States, United Kingdom, European Union, Canada, and Australia. Its portfolio includes companies such as Quoin Pharmaceuticals, YoshiHaru Global Co, Baudaux Bio, Art's Way, Major League Football, Neubase Therapeutics, Fourth Wave Energy, Motorsport Games, Adial Pharmaceuticals, RedHill Biopharma, Advanced Biological Laboratories, Femasys, VCI Global Limited, and Kazia. The firm is headquartered at 80 S.W. 8th Street Suite 2000, Miami, FL 33130, and can be contacted via email at inquiries@alumnicapital.com or by phone at (917) 793-1173. The general partner of Alumni Capital LP is Alumni Capital GP LLC, managed by Ashkan Mapar, who has voting and disposition control over the shares. The firm was established on November 30, 2021, and is registered with the Division of Corporations, Department of State in Delaware. Its Legal Entity Identifier (LEI) is 984500ECDEB043786589. The firm has been involved in various transactions, including a mutual termination of a Purchase Agreement for an ELOC facility with VCI Global Limited, effective December 11, 2025. The firm has also been involved in filings with the Securities and Exchange Commission, including a filing on November 18, 2024, related to a securities purchase agreement. The firm is active and continues to operate in the private equity and venture capital sectors, focusing on small-cap companies globally.